NEWS

Stay informed about the latest NEWS from SOCIUM.

2024-09-17	SOCIUM Inc. and Huaxi Hospital of Sichuan University have decided to conduct an investigator-initiated clinical trial of SO-002, a drug candidate for the treatment of amyotrophic lateral sclerosis (ALS)
2024-06-07	AI drug discovery venture that takes on the challenge of overcoming “unmet medical needs, SOCIUM Inc.’s paper was published in The Journal of Biomedical Research
2024-06-05	株式投資型クラウドファンディングの実施 及び オンライン事業説明会開催のお知らせ
2024-01-11	Announcement of a Strategic Alliance for the Development of Drugs for the Treatment of Rare Diseases in China
2023-10-03	Our Paper on Phosphorylation Analysis Accepted through Collaboration with Nanjing Medical University School of Pharmacy (China)
2023-09-19	Exhibit at “Japan Healthcare Venture Summit 2023”
2023-01-30	SOCIUM Inc Announces to be Awarded Third Prize in The World at JINJI LAKE STARTUP CONTEST 2022
2022-05-25	RaQualia Pharma and SOCIUM Sign Joint Research Agreement for Discovering The Orphan Indication for Compound by Using AI Technology.
2022-03-15	Sumitomo Dainippon Pharma to Collaborate with SOCIUM Joint Research Aims to Reveal Neuroprotective Mechanism in Tauopathy
2022-01-11	Tokushima University to Collaborate with SOCIUM Inc. Strategic partnership aims to AI-driven drug discovery for Rare Gastrointestinal Tumor